Summer Sale
50% off Premium Yearly
NYSE:DOCS
Doximity (DOCS)
Financials 
Technical Analysis Up 38% since IPO in fall 2021. Shares got killed last year during inflation and rate hikes. Has since rebounded. It's been a round trip. Their last report was solid, but guidance was ugly, given a delay in their new telemedicine product given regulatory interference. But they've beaten every quarter. Pricey at 47x PE 2023 but are profitable.
- «
- ‹
- 1
- ›
- »
Doximity (DOCS) Frequently Asked Questions
What is Doximity stock symbol?
Doximity is a American stock, trading under the symbol DOCS (previously DOCS-N on Stockchase) on the New York Stock Exchange (DOCS). It is usually referred to as NYSE:DOCS or DOCS
Is Doximity a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on DOCS (previously DOCS-N on Stockchase) on Stockchase. Read the latest expert commentary for Doximity.
Is Doximity a good investment or a top pick?
Doximity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Doximity.
Why is Doximity stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Doximity.
Is Doximity worth watching?
Doximity is covered by Stockchase experts and is worth watching.
What is Doximity stock price?
On 2026-06-18, Doximity (DOCS) stock closed at a price of $20.32.
